Hualan Biological Vaccine Inc. (SHE:301207)
China · Delayed Price · Currency is CNY 18.97
+0.11 (0.58%)
At close: Jan 22, 2026
Hualan Biological Vaccine Company Description
Hualan Biological Vaccine Inc. engages in the research and development, production, and sale of vaccines and genetic engineering biological products in China.
The company offers influenza vaccine (split virion), recombinant hepatitis B vaccine (hansenula polymorpha), meningococcal polysaccharide vaccine, influenza vaccine (split virion) quadrivalent, and meningococcal polysaccharide vaccine.
It also sells self-produced products. The company was founded in 2005 and is based in Xinxiang, China.
Hualan Biological Vaccine Inc.
| Country | China |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 748 |
| CEO | Wenjue An |
Contact Details
Address: Jia No. 1-1, Hualan Avenue Xinxiang, 453003 China | |
| Phone | 86 37 3355 9991 |
| Website | hualanbacterin.com |
Stock Details
| Ticker Symbol | 301207 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000058J9 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Wenjue An | GM and Director |
| Ruowen Pan | Executive Vice President and Director |
| Ke Lu | Chief Financial Officer and Secretary |